Showing results (81-90 of 161) with videos related to
Sort By:
Pageof 17
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.Cancers|November 27, 2021
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge StrategyDavide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.Journal of Experimental & Clinical Cancer Research : CR|June 6, 2019
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer modelsValentina Belli, Nunzia Matrone, Stefania Napolitano, et al.Cancers|September 28, 2021
How Immunotherapy Has Changed the Continuum of Care in Hepatocellular CarcinomaGiulia Martini, Davide Ciardiello, Fernando Paragliola, et al.International Journal of Molecular Sciences|January 21, 2022
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future PerspectivesDavide Ciardiello, Brigida Anna Maiorano, Paola Parente, et al.Oncotarget|May 4, 2018
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cellsVincenza Ciaramella, Carminia Maria Della Corte, Concetta Di Mauro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2013
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cellsTeresa Troiani, Erika Martinelli, Stefania Napolitano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2010
Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cellsErika Martinelli, Teresa Troiani, Floriana Morgillo, et al.Journal of Experimental & Clinical Cancer Research : CR|April 28, 2019
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLCVincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, et al.Healthcare (Basel, Switzerland)|April 23, 2022
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case SeriesLuigi Pio Guerrera, Gabriella Suarato, Rossella Napolitano, et al.Pageof 17